New Enterprise Associates 16, L.P. 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-17 4:22 pm Purchase | 2025-11-13 | 13D | MARKER THERAPEUTICS INC MRKR | New Enterprise Associates 16, L.P. | 1,670,081 9.900% | 44,403 (+2.73%) | Filing |
| 2025-08-18 5:34 pm Unchanged | 2025-08-14 | 13D | MARKER THERAPEUTICS INC MRKR | New Enterprise Associates 16, L.P. | 1,625,678 12.600% | 0 (Unchanged) | Filing |
| 2024-12-23 4:30 pm Purchase | 2024-12-19 | 13D | MARKER THERAPEUTICS INC MRKR | New Enterprise Associates 16, L.P. | 1,625,678 15.200% | 554,250 (+51.73%) | Filing |
| 2024-05-17 6:25 pm Sale | 2024-05-15 | 13D | MARKER THERAPEUTICS INC MRKR | New Enterprise Associates 16, L.P. | 1,071,428 12.000% | -375,001 (-25.93%) | Filing |